Trial
NCT03766126
Lentivirally Redirected CD123 Autologous T Cells in AML
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
—
Condition
Acute Myeloid Leukemia, in Relapse
Intervention
CART123 cells
Why stopped
Administrative reasons.
Provenance
Dataset: 2026-07-10 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-10